196 related articles for article (PubMed ID: 17710516)
1. One-step surface modification of poly(lactide-co-glycolide) microparticles with heparin.
Cui C; Schwendeman SP
Pharm Res; 2007 Dec; 24(12):2381-93. PubMed ID: 17710516
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
[TBL] [Abstract][Full Text] [Related]
3. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives.
Chung TW; Tsai YL; Hsieh JH; Tsai WJ
J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
5. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis.
Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425
[TBL] [Abstract][Full Text] [Related]
7. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
8. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
10. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.
Ruan G; Feng SS; Li QT
J Control Release; 2002 Dec; 84(3):151-60. PubMed ID: 12468218
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres.
Ito F; Fujimori H; Makino K
Colloids Surf B Biointerfaces; 2008 Jan; 61(1):25-9. PubMed ID: 17719753
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
13. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
[TBL] [Abstract][Full Text] [Related]
14. Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods.
Iwata M; Nakamura Y; McGinity JW
J Microencapsul; 1999; 16(1):49-58. PubMed ID: 9972502
[TBL] [Abstract][Full Text] [Related]
15. Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons.
Tan EY; Law JW; Wang CH; Lee AY
Pharm Res; 2007 Dec; 24(12):2297-308. PubMed ID: 17899323
[TBL] [Abstract][Full Text] [Related]
16. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
17. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
18. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy.
Ding AG; Schwendeman SP
Pharm Res; 2008 Sep; 25(9):2041-52. PubMed ID: 18622692
[TBL] [Abstract][Full Text] [Related]
19. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
[TBL] [Abstract][Full Text] [Related]
20. Alendronate PLGA microspheres with high loading efficiency for dental applications.
Nafea EH; El-Massik MA; El-Khordagui LK; Marei MK; Khalafallah NM
J Microencapsul; 2007 Sep; 24(6):525-38. PubMed ID: 17654173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]